Status | Study |
Not yet recruiting |
Study Name: Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition Condition: Iatrogenic Cushing's Disease Date: 2017-03-17 Interventions: Drug: AZD4017 and prednisolone |
Completed |
Study Name: Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment Condition: Cushing Disease Date: 2017-03-03 Interventions: Drug: Pasireotide 0.6 MG/ML The aim of the study was to evaluate the effect of pasireotide on β -ce |
Recruiting |
Study Name: Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease Condition: Cushing's Disease Date: 2016-02-27 Interventions: Drug: osilodrostat In the form |
Not yet recruiting |
Study Name: Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease Condition: Cushing's Disease Date: 2015-11-03 Interventions: Device: Virtual radial task in 3D The virtual radial task is a labyrinth in 3D with twelve ways. The pri |
Recruiting |
Study Name: Cushing's Disease Complications Condition: Cushing's Disease Date: 2015-07-20 Interventions: Other: Exams and questionnaires Blood sample 24hrs urinary cortisol and salivary cortisol, urinary labst |
Recruiting |
Study Name: Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease Condition: Cushing's Disease Corticotrophin Adenoma Date: 2015-06-21 Interventions: Drug: Gefitinib See Arm Description |
Active, not recruiting |
Study Name: Cushing´s Disease Epidemiology in Sweden Condition: Cushing Disease Date: 2014-12-05 |
Recruiting |
Study Name: Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Condition: Cushings Disease Date: 2014-09-26 Interventions: Drug: SOM230 |
Completed |
Study Name: The Factors Associated With the Recurrence in Patients With Cushing Disease Condition: Cushing Disease Date: 2014-08-27 |
Recruiting |
Study Name: Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease Condition: Cushing's Disease Date: 2014-06-17 Interventions: Drug: LCI699 |